Biopharmaceutical Manufacturing Volume

Biopharmaceutical Manufacturing Volume
Author :
Publisher :
Total Pages :
Release :
ISBN-10 : 0750331801
ISBN-13 : 9780750331807
Rating : 4/5 (01 Downloads)

Book Synopsis Biopharmaceutical Manufacturing Volume by : Lokesh NIAZI

Download or read book Biopharmaceutical Manufacturing Volume written by Lokesh NIAZI and published by . This book was released on 2021-10-31 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:


Biopharmaceutical Manufacturing Volume Related Books

Biopharmaceutical Manufacturing Volume
Language: en
Pages:
Authors: Lokesh NIAZI
Categories:
Type: BOOK - Published: 2021-10-31 - Publisher:

DOWNLOAD EBOOK

Biopharmaceutical Manufacturing Volume
Language: en
Pages: 350
Authors: Sarfaraz K. Niazi
Categories: Science
Type: BOOK - Published: 2022-02-25 - Publisher: IOP Publishing Limited

DOWNLOAD EBOOK

This two-volume set provides a comprehensive guide to the essential aspects of commercial biopharmaceutical manufacturing. Covering the planning, layout and ope
Biopharmaceutical Manufacturing
Language: en
Pages: 0
Authors: Sarfaraz Niazi
Categories: Pharmaceutical biotechnology
Type: BOOK - Published: 2021 - Publisher:

DOWNLOAD EBOOK

This two-volume set provides a comprehensive guide to the essential aspects of commercial biopharmaceutical manufacturing. Covering the planning, layout and ope
Biopharmaceutical Manufacturing
Language: en
Pages: 433
Authors: Gary Gilleskie
Categories: Science
Type: BOOK - Published: 2021-09-07 - Publisher: Walter de Gruyter GmbH & Co KG

DOWNLOAD EBOOK

Biopharmaceuticals, medicines made by or from living organisms (including cells from living organisms), are extremely effective in treating a broad range of dis
PAT Applied in Biopharmaceutical Process Development And Manufacturing
Language: en
Pages: 330
Authors: Cenk Undey
Categories: Medical
Type: BOOK - Published: 2011-12-07 - Publisher: CRC Press

DOWNLOAD EBOOK

As with all of pharmaceutical production, the regulatory environment for the production of therapeutics has been changing as a direct result of the US FDA-initi